Free Trial

Estrella Immunopharma (ESLA) Competitors

Estrella Immunopharma logo
$0.90 +0.04 (+4.37%)
Closing price 08/15/2025 03:20 PM Eastern
Extended Trading
$0.88 -0.02 (-2.56%)
As of 08/15/2025 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ESLA vs. TNYA, AVTX, SCLX, GNLX, ALTS, IOBT, TARA, IMRX, LIMN, and SAVA

Should you be buying Estrella Immunopharma stock or one of its competitors? The main competitors of Estrella Immunopharma include Tenaya Therapeutics (TNYA), Avalo Therapeutics (AVTX), Scilex (SCLX), Genelux (GNLX), ALT5 Sigma (ALTS), IO Biotech (IOBT), Protara Therapeutics (TARA), Immuneering (IMRX), Liminatus Pharma (LIMN), and Cassava Sciences (SAVA). These companies are all part of the "pharmaceutical products" industry.

Estrella Immunopharma vs. Its Competitors

Tenaya Therapeutics (NASDAQ:TNYA) and Estrella Immunopharma (NASDAQ:ESLA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.

In the previous week, Tenaya Therapeutics had 10 more articles in the media than Estrella Immunopharma. MarketBeat recorded 14 mentions for Tenaya Therapeutics and 4 mentions for Estrella Immunopharma. Estrella Immunopharma's average media sentiment score of 0.81 beat Tenaya Therapeutics' score of 0.39 indicating that Estrella Immunopharma is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tenaya Therapeutics
2 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Estrella Immunopharma
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tenaya Therapeutics presently has a consensus price target of $6.25, suggesting a potential upside of 438.79%. Estrella Immunopharma has a consensus price target of $16.00, suggesting a potential upside of 1,681.74%. Given Estrella Immunopharma's higher probable upside, analysts clearly believe Estrella Immunopharma is more favorable than Tenaya Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenaya Therapeutics
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Estrella Immunopharma
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Estrella Immunopharma is trading at a lower price-to-earnings ratio than Tenaya Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tenaya TherapeuticsN/AN/A-$111.13M-$0.96-1.21
Estrella ImmunopharmaN/AN/A-$7.31M-$0.26-3.45

90.5% of Tenaya Therapeutics shares are owned by institutional investors. Comparatively, 0.4% of Estrella Immunopharma shares are owned by institutional investors. 48.7% of Tenaya Therapeutics shares are owned by company insiders. Comparatively, 55.1% of Estrella Immunopharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Tenaya Therapeutics' return on equity of -93.83% beat Estrella Immunopharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Tenaya TherapeuticsN/A -93.83% -75.66%
Estrella Immunopharma N/A -1,132.38%-358.54%

Tenaya Therapeutics has a beta of 3.01, indicating that its stock price is 201% more volatile than the S&P 500. Comparatively, Estrella Immunopharma has a beta of 0.34, indicating that its stock price is 66% less volatile than the S&P 500.

Summary

Tenaya Therapeutics beats Estrella Immunopharma on 7 of the 12 factors compared between the two stocks.

Get Estrella Immunopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ESLA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ESLA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ESLA vs. The Competition

MetricEstrella ImmunopharmaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$31.89M$3.09B$5.66B$9.82B
Dividend YieldN/A2.23%3.79%4.07%
P/E Ratio-3.4520.3830.5825.12
Price / SalesN/A356.76462.42114.82
Price / CashN/A42.3037.4059.05
Price / Book-5.618.659.096.18
Net Income-$7.31M-$54.65M$3.25B$264.89M
7 Day Performance9.11%6.58%7.32%4.18%
1 Month Performance6.30%7.54%5.41%1.99%
1 Year Performance-36.31%13.73%30.66%24.22%

Estrella Immunopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ESLA
Estrella Immunopharma
3.0309 of 5 stars
$0.90
+4.4%
$16.00
+1,681.7%
-36.3%$31.89MN/A-3.45N/ANews Coverage
Analyst Forecast
Gap Up
TNYA
Tenaya Therapeutics
3.0478 of 5 stars
$0.76
+11.1%
$6.25
+725.6%
-61.3%$123.38MN/A-0.79110
AVTX
Avalo Therapeutics
3.4979 of 5 stars
$9.36
+3.9%
$30.00
+220.5%
-2.6%$123.08M$440K0.0040News Coverage
Analyst Forecast
Short Interest ↓
Gap Up
SCLX
Scilex
2.2007 of 5 stars
$17.67
+11.7%
$455.00
+2,475.0%
-58.3%$122.81M$56.59M-0.6180News Coverage
Earnings Report
High Trading Volume
GNLX
Genelux
1.762 of 5 stars
$3.19
-2.7%
$17.75
+456.4%
+67.1%$120.49M$10K-3.7110News Coverage
Positive News
Analyst Revision
ALTS
ALT5 Sigma
0.6429 of 5 stars
$5.96
-9.7%
N/A+228.2%$120.05M$18.05M0.00170News Coverage
Analyst Downgrade
Options Volume
High Trading Volume
IOBT
IO Biotech
3.0263 of 5 stars
$1.31
+24.8%
$8.67
+561.6%
+60.0%$119.24MN/A-0.8830News Coverage
Earnings Report
Analyst Forecast
Short Interest ↑
Gap Up
High Trading Volume
TARA
Protara Therapeutics
2.1774 of 5 stars
$3.07
-1.0%
$19.60
+538.4%
+47.8%$118.44MN/A-1.7830News Coverage
Earnings Report
Analyst Revision
IMRX
Immuneering
3.7359 of 5 stars
$3.25
+1.2%
$13.25
+307.7%
+248.1%$116.97M$320K-1.6660News Coverage
Earnings Report
Upcoming Earnings
Analyst Forecast
LIMN
Liminatus Pharma
N/A$4.35
-2.9%
N/AN/A$113.14MN/A0.00N/APositive News
SAVA
Cassava Sciences
2.0977 of 5 stars
$2.32
+3.1%
$2.00
-13.8%
-91.8%$112.08MN/A-1.5530News Coverage
Earnings Report

Related Companies and Tools


This page (NASDAQ:ESLA) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners